Human albumin does not prevent ovarian hyperstimulation syndrome in assisted reproductive technology program: a prospective randomized placebo-controlled double blind study

被引：28

作者：

Isikoglu, Mete ^{[1
]}

Berkkanoglu, Murat ^{[1
]}

Senturk, Zeliha ^{[1
]}

Ozgur, Kemal ^{[1
]}

机构：

[1] Antalya IVF, TR-07080 Antalya, Turkey

来源：

FERTILITY AND STERILITY | 2007年 / 88卷 / 04期

关键词：

D O I：

10.1016/j.fertnstert.2006.11.170

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

We aimed to clarify the efficiency of IV human albumin in the prevention of ovarian hyperstimulation syndrome (OHSS). We found that human albumin at the described strength does not seem to either prevent or reduce the incidence of severe OHSS in high risk patients undergoing intracytoplasmic sperm injection (ICSI).

引用

收藏

页码：982 / 985

页数：4

相关论文

共 27 条

[1]

Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review [J].

Aboulghar, M ;

Evers, JH ;

Al-Inany, H .

HUMAN REPRODUCTION, 2002, 17 (12) :3027-3032

[2]

Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures [J].

Aboulghar, MA ;

Mansour, RT .

HUMAN REPRODUCTION UPDATE, 2003, 9 (03) :275-289

[3]

THE USE OF INTRAVENOUS ALBUMIN IN PATIENTS AT HIGH-RISK FOR SEVERE OVARIAN HYPERSTIMULATION SYNDROME [J].

ASCH, RH ;

IVERY, G ;

GOLDSMAN, M ;

FREDERICK, JL ;

STONE, SC ;

BALMACEDA, JP .

HUMAN REPRODUCTION, 1993, 8 (07) :1015-1020

[4]

BALASCH J, 1991, FERTIL STERIL, V56, P1077

[5]

Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients:: a randomized controlled study [J].

Bellver, J ;

Muñoz, EA ;

Ballesteros, A ;

Soares, SR ;

Bosch, E ;

Simón, C ;

Pellicer, A ;

Remohí, J .

HUMAN REPRODUCTION, 2003, 18 (11) :2283-2288

[6]

The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial [J].

Ben-Chetrit, A ;

Eldar-Geva, T ;

Gal, M ;

Huerta, M ;

Mimon, T ;

Algur, N ;

Diamant, YZ ;

Margalioth, EJ .

HUMAN REPRODUCTION, 2001, 16 (09) :1880-1884

[7]

Use of intramuscular progesterone versus intravenous albumin for the prevention of ovarian hyperstimulation syndrome [J].

Costabile, L ;

Unfer, V ;

Manna, C ;

Gerli, S ;

Rossetti, D ;

Di Renzo, GC .

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 50 (03) :182-185

[8]

New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? [J].

Delbaere, A ;

Smits, G ;

Olatunbosun, O ;

Pierson, R ;

Vassart, G ;

Costagliola, S .

HUMAN REPRODUCTION, 2004, 19 (03) :486-489

[9]

ERLIK Y, 1979, OBSTET GYNECOL, V53, P580

[10]

European Recombinant LH Study Group, 2001, J Clin Endocrinol Metab, V86, P2607